Last reviewed · How we verify
NCT05090631
The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh Population
trial testing DNA analysis in Atopic Dermatitis in 600 participants. Completed in 20 January 2023.
20 January 2023
Quick facts
| Lead sponsor | Asfendiyarov Kazakh National Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 23 October 2021 |
| Primary completion | 20 January 2023 |
| Estimated completion | 20 January 2023 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- DNA analysis
Conditions studied
- Atopic Dermatitis — all drugs for Atopic Dermatitis →
Sponsor
Asfendiyarov Kazakh National Medical University
Who can join
Adults 18 to 45, any sex, with Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a GWAS study that aims to identify possible candidate genes associate to atopic dermatitisby exploring single nucleotide polymorphism (SNP) in a group of atopic dermatitis, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with atopic dermatitis
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of the quality of life in patients with atopic dermatitis using the Kazakh version of the questionnaire "Dermatology Life Quality Index".
Sarybayeva G, Beisebayeva U, Almenova L, Khabizhanov A, et al · · 2025 · PMID 40718125 · DOI 10.5415/apallergy.0000000000000183
Verify or expand the search:
- PubMed search for NCT05090631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DNA analysis
Trials testing the same drug.
- NCT05090605 — The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population · completed
- NCT05088486 — The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population · completed
- NCT05090644 — Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on t · completed
- NCT05088499 — The Role of Genetic Factors in the Development of Epilepsy in the Kazakh Population · completed
- NCT05090618 — The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population · completed
Other recruiting trials for Atopic Dermatitis
Currently open trials in the same condition.
- NCT07262983 — Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi · Phase 1 · recruiting
- NCT07445919 — A Clinical Study to Evaluate SM17 for Atopic Dermatitis · Phase 2 · recruiting
- NCT07488065 — A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants · Phase 1 · recruiting
- NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatit · recruiting
- NCT07358156 — A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E · Phase 1 · recruiting
Other Asfendiyarov Kazakh National Medical University trials
Trials by the same sponsor.
- NCT06953180 — Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
- NCT05970861 — Effect of Natural Food on Gut Microbiome and Phospholipid Spectrum of Immune Cells in COVID-19 Patients · NA · completed
- NCT05095155 — Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Ka · completed
- NCT05090644 — Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on t · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05090631 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asfendiyarov Kazakh National Medical University
- Last refreshed: 14 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05090631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing